Curr Pain Headache Rep. 2009 Oct;13(5):358-64.
Neuroendocrine dysfunction in fibromyalgia and migraine.
Valença MM, Medeiros FL, Martins HA, Massaud RM, Peres MF. Instituto Israelita deEnsino e Pesquisa Hospital Albert Einstein, Al Joaquim Eugenio de Lima, 881 cj 708, 01403-001, Sao Paulo, Brazil. This email address is being protected from spambots. You need JavaScript enabled to view it..
Fibromyalgia (FM) and migraine are common chronic disorders that predominantly affect women. The prevalence of headache in patients with FM is high (35%-88%), with migraine being the most frequent type. A particular subgroup of patients with FM (approximately half) presents with a combined clinical form of these two painful disorders, which may exhibit a different manner of progression regarding symptomatology and impact on daily activities. This article reviews several common aspects of the pathophysiology regarding pain control mechanisms and neuroendocrine dysfunction occurring in FM and migraine, particularly in the chronic form of the latter. We also discuss the participation of hypothalamic and brainstem centers of pain control, the putative role played by neurotransmitters or neuromodulators on central sensitization, and changes in their levels in the cerebrospinal fluid. Understanding their mechanisms will help to establish new treatment strategies for treating these disabling brain disorders.
PMID: 19728961 [PubMed - in process]
{mosgoogle}
{mos_sb_discuss:9}
Please Help Support EiR with a Positive Google Review!
If you like EiR and / or enoyed this content; please help us keep going by leaving a Positive Google Review:
Review EiR on Google NOW!
P.S. This is entirely secure, we collect no data other than what is freely available from Google and you can remain anonymous!
Related Articles:
Mold Testing & Sanitizer:
ADVERTISEMENT
